Mitral Valve

Editor's choice


Transseptal Transcatheter Mitral Valve Replacement for Post-Surgical Mitral Failures

Approximately 1.8 % of the US population has mitral valve disease,1 and an estimated 106,000 surgeries per year are for the treatment of valvular heart disease.2 A total of 210,529 mitral surgeries were performed from 2000 to 2007, averaging approximately 30,000 mitral valve surgeries yearly in the US, accounting for both combined and isolated mitral procedures, with approximately 60 % of surgeries using a bioprosthetic valve.3 Unfortuna

Erratum to: Minimally Invasive Surgical Mitral Valve Repair: State of the Art Review

For the paper entitled ‘Minimally Invasive Surgical Mitral Valve Repair: State of the Art Review’, which appeared in Interventional Cardiology Review 2018;13(1):14–9, the source for Tables 1–2 and Figure 1 is shown as: ‘Courtesy of Professor Volkmar Falk; adapted from Baumgartner, et al., 2017’. The statement of source should be: ‘Baumgartner H, et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J 2017;38(36):2739–91.

The Changing Paradigm in the Treatment of Structural Heart Disease and the Need for the Interventional Imaging Specialist

Over the past 30 years, several percutaneous transcatheter technologies and devices for interventions in structural heart diseases (SHDs) have been introduced (see Table 1). There are numerous technologies that are in development or are currently being used to treat patients with SHD that use transcatheter techniques. The variety of percutaneous treatment approaches has led to a revolution and evolution in clinical care. The past few years have seen a greater application of novel, catheter-based treatments for SHDs.

Hybrid Imaging in the Catheter Laboratory: Real-time Fusion of Echocardiography and Fluoroscopy During Percutaneous Structural Heart Disease Interventions

Percutaneous catheter-based structural heart disease procedures are a rapidly growing area of interventional cardiology, and represent a valuable option for cardiac patients with comorbidities who are ineligible for conventional surgery as well as demonstrating excellent outcomes.1,2 Catheter-based interventions include transcatheter aortic valve implantation (TAVI),3 percutaneous mitral valve (MV) repair,4 atrial septal defect (ASD) closure, percutaneous closure of paravalvular leakages (PVL)5 and left atrial appendage (LAA) clo